FR2230374A1 - Phosphonates contg. a P-32 or P-33 radionuclide - prepd. by reaction of labelled phosphorus trichloride and acid - Google Patents

Phosphonates contg. a P-32 or P-33 radionuclide - prepd. by reaction of labelled phosphorus trichloride and acid

Info

Publication number
FR2230374A1
FR2230374A1 FR7417965A FR7417965A FR2230374A1 FR 2230374 A1 FR2230374 A1 FR 2230374A1 FR 7417965 A FR7417965 A FR 7417965A FR 7417965 A FR7417965 A FR 7417965A FR 2230374 A1 FR2230374 A1 FR 2230374A1
Authority
FR
France
Prior art keywords
cpds
tumours
labelled
contg
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7417965A
Other languages
English (en)
French (fr)
Other versions
FR2230374B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of FR2230374A1 publication Critical patent/FR2230374A1/fr
Application granted granted Critical
Publication of FR2230374B1 publication Critical patent/FR2230374B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7417965A 1973-05-23 1974-05-22 Phosphonates contg. a P-32 or P-33 radionuclide - prepd. by reaction of labelled phosphorus trichloride and acid Granted FR2230374A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36297173A 1973-05-23 1973-05-23

Publications (2)

Publication Number Publication Date
FR2230374A1 true FR2230374A1 (en) 1974-12-20
FR2230374B1 FR2230374B1 (enExample) 1978-07-21

Family

ID=23428261

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7417965A Granted FR2230374A1 (en) 1973-05-23 1974-05-22 Phosphonates contg. a P-32 or P-33 radionuclide - prepd. by reaction of labelled phosphorus trichloride and acid

Country Status (6)

Country Link
BE (1) BE815397A (enExample)
DE (1) DE2424453C3 (enExample)
FR (1) FR2230374A1 (enExample)
NL (1) NL7406952A (enExample)
PH (1) PH12898A (enExample)
ZA (1) ZA743159B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076556A3 (en) * 1999-07-11 2001-10-11 Neorx Corp High dose radionuclide complexes for bone marrow suppression
EP1426063A3 (en) * 2000-02-18 2004-07-14 Civatech Corporation Brachytherapy seeds and stents that can be activated by neutron rays
US7118729B1 (en) 1999-07-12 2006-10-10 Civatech Corporation Radioactive source materials formable into various shapes
US7686756B2 (en) 2006-08-29 2010-03-30 Ciratech Oncology Brachytherapy devices and related methods and computer program products

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
EP1390081A2 (en) 2001-01-08 2004-02-25 Neorx Corporation Therapeutic and diagnostic compounds, compositions, and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076556A3 (en) * 1999-07-11 2001-10-11 Neorx Corp High dose radionuclide complexes for bone marrow suppression
US7118729B1 (en) 1999-07-12 2006-10-10 Civatech Corporation Radioactive source materials formable into various shapes
US8012455B2 (en) 1999-07-12 2011-09-06 Civatech Corporation Radioactive source materials formable into various shapes
EP1426063A3 (en) * 2000-02-18 2004-07-14 Civatech Corporation Brachytherapy seeds and stents that can be activated by neutron rays
US7686756B2 (en) 2006-08-29 2010-03-30 Ciratech Oncology Brachytherapy devices and related methods and computer program products
US9358377B2 (en) 2006-08-29 2016-06-07 Civatech Onocology Brachytherapy devices and related methods and computer program products

Also Published As

Publication number Publication date
DE2424453C3 (de) 1981-02-26
BE815397A (fr) 1974-11-22
DE2424453B2 (de) 1980-06-12
FR2230374B1 (enExample) 1978-07-21
DE2424453A1 (de) 1974-12-12
PH12898A (en) 1979-10-04
ZA743159B (en) 1975-05-28
NL7406952A (enExample) 1974-11-26

Similar Documents

Publication Publication Date Title
SE7708170L (sv) Rengoringsmedel for tandproteser
FR2230374A1 (en) Phosphonates contg. a P-32 or P-33 radionuclide - prepd. by reaction of labelled phosphorus trichloride and acid
ES416948A1 (es) Procedimiento para la obtencion de esteres de acido difos- finico.
JPS522910A (en) Mono rail car
ES2090787T3 (es) Compuestos quelantes que poseen funcionalidad de ligacion en posicion orto y sus complejos.
ES357089A1 (es) Procedimiento para la preparacion de aminoesteres del acido4-pentionico-2-sustituido.
ES431896A1 (es) Procedimiento para remineralizar el esmalte dental desmine- ralizado.
FR2303766A1 (fr) Elimination de matieres oxydables des eaux polluees
ES414069A1 (es) Un procedimiento para purificar acido fosforico obtenido por el proceso humedo.
ATE17226T1 (de) Verfahren zur korrosionsschutzbehandlung wasserfuehrender systeme.
JPS5610200A (en) Anthracycline glycoside* its manufacture and medicinal composition containing same for tumor treatment
ES422967A1 (es) Procedimiento para preparar un compuesto solido a partir deacido fosforico.
DE3365840D1 (en) Detergent liquors and compositions for use therein
TW225538B (enExample)
ES2004065A6 (es) Valvula de goteo para una plancha de vapor electricamente calentada
FR2300796B1 (enExample)
ES411710A1 (es) Procedimiento para la preparacion de nitroimidazolil-tria- zolo-piridazinas.
ES8104912A1 (es) Procedimiento para la preparacion de un producto medicamen- toso anticanceroso, asi como la profilaxis y metodo de tra- tamiento para su aplicacion
BE800689A (en) Inhibiting calcium phosphate mobilise - with agents contg org phosphonic acids and vitamins
ES402285A1 (es) Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica.
FR2429021A1 (fr) Composition pharmaceutique utile dans le traitement de diverses maladies par action sur le systeme reticuloendothelial et application de cette composition au traitement de tumeurs malignes en therapeutique humaine
HUT64478A (en) Process for producing medical preparatives for treatment of b-cell tumours
SU1062209A1 (ru) 2-(Морфолил- @ -этокси)-4-метил-3,4-дигидропиран в качестве стабилизирующей добавки к полиуретановой композиции
SUH et al. Etoposide and cisplatin combination chemotherapy in extensive stage small cell lung cancer
GR3000523T3 (en) Diamine platinum (ii) complex compounds with a hydroxy-substituted 2-phenyl-indole ring

Legal Events

Date Code Title Description
ST Notification of lapse